glp-1 news today 2025 november 5 Pipeline Update: - Prime Therapeutics You're on Ozempic? How Quaint.

The GLP-1 receptor drives glucose-dependent insulin release and slows gastric emptying, which reduces food intake

glipizide as add-on therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: long-term (52-week) extension of a 52-week randomised controlled trial

It works by reducing melanin production, which helps minimize dark spots and discoloration, giving the skin a more radiant look

It is all connected

The FDA evaluates nominated substances using a balancing test that considers physical and chemical characterization, safety issues, available evidence of effectiveness or lack of effectiveness, and historical use in compounding

If you notice a hard spot developing, avoid that area entirely for at least 4-6 weeks